Review: Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes

S. L. Norris; X. Zhang; A. Avenell

doi:10.1136/ebm.10.1.12

Review: Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes

S. L. Norris, X. Zhang, A. Avenell

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	12
Number of pages	1
Journal	Evidence-Based Medicine
Volume	10
Issue number	1
DOIs	https://doi.org/10.1136/ebm.10.1.12
State	Published - Feb 2005
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/ebm.10.1.12

Cite this

@article{26ae71a301fc43bb9f7cfde6854ff65b,

title = "Review: Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes",

author = "Norris, {S. L.} and X. Zhang and A. Avenell",

year = "2005",

month = feb,

doi = "10.1136/ebm.10.1.12",

language = "English (US)",

volume = "10",

pages = "12",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Review

T2 - Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes

AU - Norris, S. L.

AU - Zhang, X.

AU - Avenell, A.

PY - 2005/2

Y1 - 2005/2

UR - http://www.scopus.com/inward/record.url?scp=13844317888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844317888&partnerID=8YFLogxK

U2 - 10.1136/ebm.10.1.12

DO - 10.1136/ebm.10.1.12

M3 - Short survey

AN - SCOPUS:13844317888

SN - 1356-5524

VL - 10

SP - 12

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 1

ER -

Review: Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this